Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
Hongmei Yan, Weiyun Wu, Xinxia Chang, et al.
Biology of Sex Differences (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)
Patrizia Burra, Debora Bizzaro, Anna Gonta, et al.
Liver International (2021) Vol. 41, Iss. 8, pp. 1713-1733
Open Access | Times Cited: 113
Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts
Pei Chia Eng, Roberta Forlano, Tricia Tan, et al.
JHEP Reports (2023) Vol. 5, Iss. 10, pp. 100835-100835
Open Access | Times Cited: 31
Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials
Zeyu Wang, Du Huiqing, Ying Zhao, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 25
What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
Marcin Kosmalski, Rafał Frankowski, Sylwia Ziółkowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1852-1852
Open Access | Times Cited: 22
Unlocking Gender-Based Health Insights with Predictive Analytics
Vinod Kumar, Chander Prabha
(2025), pp. 141-165
Closed Access
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents
Andrea del Carmen Maldonado-Rojas, Julia María Zuarth-Vázquez, Misael Uribe, et al.
Annals of Hepatology (2023) Vol. 29, Iss. 2, pp. 101182-101182
Open Access | Times Cited: 13
Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease—Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Florentina Ioniţă‐Radu, Cristina Patoni, Andreea Simona Nancoff, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4201-4201
Open Access | Times Cited: 4
Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: A 3‐year prospective cohort study
Ming‐Ling Chang, Jennifer Tai, Jur‐Shan Cheng, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 7, pp. 2969-2978
Closed Access | Times Cited: 4
Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
Swati Katoch, Vinesh Sharma, Vikram Patial
World Journal of Gastroenterology (2022) Vol. 28, Iss. 28, pp. 3535-3554
Open Access | Times Cited: 21
Vitamin E and Pioglitazone: A Comprehensive Systematic Review of Their Efficacy in Non-alcoholic Fatty Liver Disease
Iqra Mazhar, Mohamed Yasir, Saba Sarfraz, et al.
Cureus (2023)
Open Access | Times Cited: 10
Addressing the preventive and therapeutic perspective of berberine against diabetes
Suyesh Shrivastava, Anamika Sharma, Nishant Saxena, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21233-e21233
Open Access | Times Cited: 10
Discovery of 2-deoxy glucose surfaced mixed layer dendrimer: a smart neuron targeted systemic drug delivery system for brain diseases
Anubhav Dhull, Zhi Zhang, Rishi Sharma, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3221-3245
Open Access | Times Cited: 3
The PPARγ agonist pioglitazone produces a female-predominant inhibition of hyperalgesia associated with surgical incision, peripheral nerve injury, and painful diabetic neuropathy
Diogo Francisco da Silva dos Santos, Renée R. Donahue, Don E. Laird, et al.
Neuropharmacology (2021) Vol. 205, pp. 108907-108907
Open Access | Times Cited: 19
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes
Anna Licata, Giuseppina Russo, Annalisa Giandalia, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 558-558
Open Access | Times Cited: 3
N-Acetyl-l-tryptophan inhibits CCl4-induced hepatic fibrogenesis via regulating TGF-β1/SMAD and Hippo/YAP1 signal
Tingting Ma, Huanli Cheng, Tongxi Li, et al.
Bioorganic Chemistry (2022) Vol. 126, pp. 105899-105899
Closed Access | Times Cited: 5
Impact of occupational noise exposure on the hearing level in hospital staffs: a longitudinal study
Tang-Chuan Wang, You-Cheng Yu, Alan Y. Hsu, et al.
Environmental Science and Pollution Research (2024) Vol. 31, Iss. 16, pp. 24129-24138
Closed Access
Association of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic Syndrome in Adult Population: A Narrative Review
Isha Patel, Arti Yadav, Suchit Swaroop
Journal of Ecophysiology and Occupational Health (2024), pp. 123-130
Open Access
Differences Between Men and Women in Pain: More Than a Matter of Perception
Serge Marchand
Springer eBooks (2024), pp. 269-291
Closed Access
Sex-Dependent Differences in the Elemental Composition of Internal Organs Determined via Total Reflection X-Ray Fluorescence and Inductively Coupled Plasma Optical Emission Spectroscopy
Aleksandra Wilk, Zuzanna Setkowicz, Katarzyna Matusiak, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2774-2774
Open Access
Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Chunye Zhang, Yuxiang Sui, Shuai Liu, et al.
(2023), pp. 246-275
Open Access | Times Cited: 1
Effectiveness of Lifestyle Interventions for Nonalcoholic Fatty Liver Disease Treatment
Abdelilah Arredouani
IntechOpen eBooks (2022)
Open Access | Times Cited: 2
UEG position paper: Obesity and digestive health
Patrizia Burra, Marianna Arvanitakis, Jorge Amil Dias, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 10, pp. 1199-1201
Open Access | Times Cited: 2
Personalized glucose-lowering effect of chiglitazar in type 2 diabetes
Qi Huang, Xiantong Zou, Yingli Chen, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108195-108195
Open Access
Page 1

Scroll to top